Pharmafile Logo
Pharmafocus logo
Advanced Search

Cancer

Showing 15 posts of 1067 posts found.

AstraZeneca imge

AZ begins late-stage trial of new cancer drug

October 22, 2013
Research and Development, Sales and Marketing AstraZeneca, Cancer, NSCLC, selumetinib

AstraZeneca has begun a Phase III study for its investigational lung cancer pill selumetinib in patients with a genetic sub-type …

News
Herceptin image

The new paradigm in oncology drug marketing

October 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Herceptin, Roche, marketing, oncology

Twenty years ago drugs to treat cancer were made up of chemotherapy agents which are essentially ‘blunt tools’ against the …

Feature
Roche image

Roche rules out merger talk

October 18, 2013
Sales and Marketing Cancer, Herceptin, Novartis, Roche, merger

Roche has dismissed talk of merging with fellow Swiss manufacturer Novartis as it revealed its results for the last three …

News

Astellas gets NICE nod

October 18, 2013
Sales and Marketing Cancer, NHS, NICE, Xtandi

Astellas Pharma’s new prostate cancer drug Xtandi which has been shown to shrink and kill cancer cells, has been recommended …

News
astrazeneca image

AstraZeneca pays $460m for cancer specialists

October 15, 2013
Research and Development, Sales and Marketing ADC, AstraZeneca, Cancer, MedImmune, spirogen

AstraZeneca’s biologics arm MedImmune has bought cancer biotech firm Spirogen and set up a licensing deal with ADC Therapeutics for …

News

Billions spent on European cancer care

October 15, 2013
Research and Development, Sales and Marketing Cancer, Europe, Lancet, Oxford, Pfizer

A new report has shown that cancer cost the European Union a total of €126 billion in 2009, with healthcare …

News
Vaccine image

Calls to end UK anti-vaccine magazine

October 2, 2013
Medical Communications, Sales and Marketing Cancer, Vaccine, sense about science

British retailers like Tesco and WH Smiths are being urged to drop an anti-vaccine magazine as it could be dangerous …

News

Cancer survival rates linked to government spending in EU

October 1, 2013
Research and Development, Sales and Marketing CDF, Cancer, EU, NICE

The bigger an EU country’s healthcare budget, the greater its cancer patients’ prospects of survival, according to new research released …

News
ema_building_face_web

CHMP recommends cancer ‘smart bomb’

September 23, 2013
Research and Development, Sales and Marketing CHMP, Cancer, EMA, Kadcyla, Roche

News
teva_copy

Teva in Cancer Research UK tie-up

September 20, 2013
Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer, R&D, Teva

News
Bayer image

Bayer partners with US academics

September 13, 2013
Research and Development, Sales and Marketing Bayer, Cancer, broad, oncology

Bayer HealthCare and a prestigious US academic institution have signed a five-year deal to find new oncology treatments. The German …

News
astrazeneca image

AstraZeneca pays Merck for cancer drug

September 11, 2013
Sales and Marketing AstraZeneca, Cancer, Merck, WEE1

AstraZeneca is to pay $50 million up front to get a worldwide licensing deal for one of Merck’s investigational drugs …

News
pfizer_reflection

Oxford BioMedica gains $1 million Pfizer pay-out

August 29, 2013
Research and Development, Sales and Marketing Cancer, Oxford BioMedica, Pfizer, TroVax

News
NICE image

‘Inequality’ for Welsh cancer patients

August 28, 2013
Sales and Marketing CDF, Cancer, England, NHS, NICE, Wales

Cancer sufferers in England are four times more likely to receive newer treatments on the NHS than patients in Wales, …

News
astrazeneca_alderley

AstraZeneca buys cancer specialist

August 27, 2013
Research and Development, Sales and Marketing Amplimmune, AstraZeneca, Cancer, MedImmune

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026